Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 21.90 INR
Change Today +1.35 / 6.57%
Volume 6.0K
As of 6:10 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

resonance specialties ltd (RES) Snapshot

Open
21.00
Previous Close
20.55
Day High
23.00
Day Low
20.50
52 Week High
09/12/14 - 27.50
52 Week Low
08/14/14 - 11.56
Market Cap
252.8M
Average Volume 10 Days
4.9K
EPS TTM
1.11
Shares Outstanding
11.5M
EX-Date
--
P/E TM
19.7x
Dividend
0.50
Dividend Yield
2.28%
Current Stock Chart for RESONANCE SPECIALTIES LTD (RES)

Related News

No related news articles were found.

resonance specialties ltd (RES) Related Businessweek News

No Related Businessweek News Found

resonance specialties ltd (RES) Details

Resonance Specialties Limited manufactures and sells pyridines and its derivatives in India. Its products comprise pyridine, a chemical used in the manufacture of agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; picolines, including alpha picoline used in the vinyl latex rubber, beta picoline used in the manufacture of vitamin B3, and gamma picoline used for the manufacture of anti-tuberculosis drugs; and cyanopyridines that are used in the manufacture of Vitamin B3 and anti-tuberculosis drugs. The company’s drug intermediates and active pharmaceutical ingredients include nutritional products, such as zinc picolinate, chromium picolinate, chromium polynicotinate, niacin, and niacinamide; anti-tuberculosis products, including isoniazid; and drug intermediates comprising picolinic and dipicolinic acids. In addition, it offers lutidines for use in anti-ulcer drugs, including omeprazol, lansaprazole, and rebaprazole; and collidine that is used in the manufacture of omeprazole and vitamin D3. Resonance Specialties Limited exports its products worldwide through supply agreements with various multinationals, as well as through direct exports. The company, formerly known as Armour Polymers Limited, was incorporated in 1989 and is headquartered in Mumbai, India.

Founded in 1989

resonance specialties ltd (RES) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 2.9M
Whole-Time Director
Total Annual Compensation: 893.3K
Compensation as of Fiscal Year 2014.

resonance specialties ltd (RES) Key Developments

Resonance Specialties Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Resonance Specialties Limited announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported total income from operations of INR 99.686 million against INR 98.625 million a year ago. Profit from operations before finance costs and exceptional items was INR 1.938 million against loss of INR 4.284 million a year ago. Loss from ordinary activities before tax was INR 0.222 million against profit of INR 4.739 million a year ago. Net profit from ordinary activities after tax was INR 0.731 million or INR 0.06 per basic and diluted share against INR 5.040 million or INR 0.44 per basic and diluted share a year ago. For the full year, the company reported total income from operations of INR 388.915 million against INR 450.694 million a year ago. Profit from operations before finance costs and exceptional items were INR 9.803 million against INR 17.802 million a year ago. Profit from ordinary activities before tax was INR 13.799 million against INR 10.347 million a year ago. Net profit from ordinary activities after tax was INR 12.758 million or INR 1.11 per basic and diluted share against INR 10.259 million or INR 0.89 per basic and diluted share a year ago.

Resonance Specialties Ltd Approves Dividend; Approves Management Changes

Resonance Specialties Ltd. has informed that the Board of Directors of the company at its meeting held on May 30, 2015, has approved dividend of 5% on the equity shares of INR 10.00 each. The company also approved the resignation of Ms. Sneha Gandhi as Company Secretary and Compliance officer of the company and appointed Mr. Navin Agarwal as Company Secretary and Compliance Officer of the company.

Resonance Specialties Limited to Report Q4, 2015 Results on May 30, 2015

Resonance Specialties Limited announced that they will report Q4, 2015 results on May 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RES:IN 21.90 INR +1.35

RES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RES.
View Industry Companies
 

Industry Analysis

RES

Industry Average

Valuation RES Industry Range
Price/Earnings 19.4x
Price/Sales 0.7x
Price/Book 1.2x
Price/Cash Flow 10.2x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESONANCE SPECIALTIES LTD, please visit www.resonancesl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.